XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

124 hedge funds and large institutions have $807M invested in Intersect ENT, Inc in 2021 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$262K
Puts
$1.91M
Net Calls
Net Calls Change

Top Buyers

1 +$69.6M
2 +$61.4M
3 +$39.2M
4
AAM
Alpine Associates Management
Florida
+$37.9M
5
Morgan Stanley
Morgan Stanley
New York
+$15.2M

Top Sellers

1 -$82.1M
2 -$59.5M
3 -$19.2M
4
Jennison Associates
Jennison Associates
New York
-$15.5M
5
GPP
Great Point Partners
Connecticut
-$12M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$7.19M
27
$6.91M
28
$6.61M
29
$6.21M
30
$5.63M
31
$5.38M
32
$4.9M
33
$4.76M
34
$4.64M
35
$4.42M
36
$4.41M
37
$3.44M
38
$3.22M
39
$3.09M
40
$3.08M
41
$2.99M
42
$2.92M
43
$2.63M
44
$2.61M
45
$2.58M
46
$2.54M
47
$2.48M
48
$2.47M
49
$2.45M
50
$2.4M